You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's continued, careful oversight of the REMS associated with transmucosal immediate-release fentanyl products

News provided by

U.S. Food and Drug Administration

Aug 01, 2018, 11:49 ET